한글목차

세계 착상전 유전자 진단(PGD) 시장은 2025년에는 6,160만 달러, 2032년에는 1억 4,200만 달러에 달할 것으로 예상되며, 2025년부터 2032년까지 7.8%의 연평균 성장률(CAGR)을 나타낼 것으로 예상됩니다.

그림. 2025년 지역별 이식 전 유전자 진단 시장 점유율(%)

착상전 유전자 진단(PGD)은 착상 전 배아에서 하나 또는 몇 개의 세포를 생검하여 유전적 결함을 검사하는 체외수정법으로, 체외수정으로 만들어진 배아의 유전적 이상을 확인하고 건강한 배아를 선택적으로 이식하는 데 도움이 됩니다. 유전성 질환이 자손에게 전염되는 것을 방지하고, 유전적 질환이 없는 배아만을 선택할 수 있습니다. 불임률 증가, 모성 연령 증가에 따른 염색체 이상 위험 증가, 유전 질환 예방에 대한 관심 증가, PGD 기술의 기술 발전 등의 요인이 예측 기간 동안 전 세계 착상전 유전자 진단(PGD) 시장의 성장을 가속할 것으로 예상됩니다.

시장 역학

세계 이식 전 유전자 진단 시장의 성장은 불임률 증가, 유전적 질환 예방에 대한 관심 증가, 전 세계 산모 연령 증가로 인한 염색체 이상 발생 가능성 증가에 기인하고 있습니다. 그러나 착상전 유전자 진단(PGD)의 한계, 착상전 유전자 진단(PGD)에 대한 사회적, 윤리적 우려, 엄격한 규제 등이 시장 성장을 저해할 수 있으며, PGD에 대한 인식을 확산시키기 위한 정부 및 민간 단체의 다양한 노력은 유리한 시장 성장 기회를 제공할 수 있습니다. 시장 참여자들은 차세대 염기서열 분석과 같은 새로운 기술에 주목하여 종합적인 염색체 검사를 제공하고 결과를 개선하고 있습니다.

본 조사의 주요 특징

• 세계의 이식 전 유전자 진단 시장을 상세하게 분석하여 2024년을 기준 연도로 하여 예측 기간(2025-2032년) 시장 규모와 연평균 성장률(CAGR)을 조사 분석하여 전해드립니다.
• 다양한 부문에 걸친 잠재적 수익 창출 기회를 파악하고, 이 시장의 매력적인 투자 제안 매트릭스를 설명합니다.
• 또한 시장 성장 촉진요인, 억제요인, 기회, 신제품 출시 및 승인, 시장 동향, 지역별 전망, 주요 기업의 경쟁 전략 등에 대한 중요한 고찰을 제공합니다.
• 이 보고서는 기업 하이라이트, 제품 포트폴리오, 주요 하이라이트, 성과, 전략 등의 매개 변수를 기반으로 전 세계 이식 전 유전자 진단 시장의 주요 기업을 프로파일링합니다.
• 이 보고서의 통찰력을 통해 마케팅 담당자와 기업 경영진은 향후 제품 출시, 유형화, 시장 확대, 마케팅 전술에 대한 정보에 입각한 의사결정을 내릴 수 있습니다.
• 세계 이식 전 유전자 진단 시장 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 시장 진출기업, 재무 분석가 등 다양한 이해관계자를 대상으로 합니다.
• 이해관계자들은 세계 이식 전 유전자 진단 시장 분석에 사용되는 다양한 전략 매트릭스를 통해 의사결정을 용이하게 할 수 있습니다.

목차

제1장 조사 목적과 전제조건

• 조사 목적
• 전제조건
• 약어

제2장 시장 전망

• 보고서 설명
  • 시장 정의와 범위
• 주요 요약
• Coherent Opportunity Map(COM)

제3장 시장 역학, 규제, 동향 분석

• 시장 역학
  • 성장 촉진요인
  • 성장 억제요인
  • 기회
• 영향 분석
• 시장 동향
• 주요 발전
• 규제 시나리오
• 인수와 제휴 시나리오
• 자금조달과 투자
• PEST 분석
• Porter의 Five Forces 분석

제4장 세계의 착상전 유전자 진단(PGD) 시장 - 코로나바이러스(COVID-19) 팬데믹의 영향

• 전체적인 영향
• 정부 이니셔티브
• 시장에 대한 COVID-19의 영향

제5장 세계의 착상전 유전자 진단(PGD) 시장, 유형별, 2020년-2032년

• 염색체 이상
• 이수성
• X-연관질환
• 단일 유전자 질환
• HLA Typing
• 성별 선택
• 기타

제6장 세계의 착상전 유전자 진단(PGD) 시장, 최종사용자별, 2020년-2032년

• 진단 실험실
• 병원
• 클리닉
• 기타

제7장 세계의 착상전 유전자 진단(PGD) 시장, 지역별, 2020년-2032년

• 북미
• 라틴아메리카
• 유럽
• 아시아태평양
• 중동
• 아프리카

제8장 경쟁 구도

• 기업 개요
  • PerkinElmer, Inc.
  • Genea Limited
  • Thermo Fisher Scientific Inc.
  • Agilent Technologies, Inc.
  • Quest Diagnostics Incorporated
  • Illumina, Inc.
  • CooperSurgical, Inc.
  • Beijing Genomics Institute(BGI)
  • LabCorp of America Holdings(Laboratory Corporation of America)
  • Natera, Inc.
  • Oxford Gene Technology
  • California Pacific Medical Center
  • Good Start Genetics, Inc.
  • Invitae Corporation
  • F. Hoffmann-La Roche AG
  • Progenesis

제9장 애널리스트 추천 사항

• 기회
• 애널리스트의 견해
• Coherent Opportunity Map

제10장 참고 문헌과 조사 방법

• 참고 문헌
• 조사 방법

영문목차

Global Preimplantation Genetic Diagnosis Market is estimated to be valued at USD 61.6 Mn in 2025 and is expected to reach USD 104.2 Mn by 2032, growing at a compound annual growth rate (CAGR) of 7.8% from 2025 to 2032.

Figure. Preimplantation Genetic Diagnosis Market Share (%), By Region 2025

Preimplantation genetic diagnosis (PGD) is an in-vitro fertilization procedure in which one or few cells are biopsied from an embryo before implantation and tested for genetic defects. PGD helps to identify genetic defects in embryos developed through IVF and assists in selective implantation of healthy embryos. It aids in preventing the transmission of hereditary disorders to offspring and allows couples to choose only embryos without genetic conditions. Factors such as rising infertility rates, increasing risk of chromosomal abnormalities with advancing maternal age, growing focus on prevention of genetic disorders, and technological advancements in PGD techniques can drive the global preimplantation genetic diagnosis market growth during the forecast period.

Market Dynamics:

Global preimplantation genetic diagnosis market growth is driven by rising infertility rates, growing focus on prevention of genetic disorders, increasing maternal age globally that leads to higher chances of chromosomal abnormalities. However, limitations of PGD, social and ethical concerns regarding PGD, and stringent regulations can hamper the market growth. Various initiatives by government and private organizations to spread awareness about PGD can offer lucrative market growth opportunities. Market players are focusing on new techniques such as next-generation sequencing to provide comprehensive chromosome screening with improved outcomes.

Key Features of the Study:

• This report provides in-depth analysis of the global preimplantation genetic diagnosis market, and provides market size (USD Million) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global preimplantation genetic diagnosis market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
• Key companies covered as a part of this study include CooperSurgical, Illumina, Thermo Fisher, Agilent Technologies, PerkinElmer, Abbott Laboratories, Natera, Rubicon Genomics, Oxford Gene Technology, Yikon Genomics
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• Global preimplantation genetic diagnosis market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global preimplantation genetic diagnosis market

Detailed Segmentation-

• By Type:
  • Chromosomal Abnormalities
  • Aneuploidy
  • X-linked diseases
  • Single gene disorders
  • HLA Typing
  • Gender Selection
  • Others
• By End User
  • Diagnostic Laboratories
  • Hospitals
  • Clinics
  • Others
• By Region:
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East
  • Africa
• Company Profiles:
  • PerkinElmer, Inc.
  • Genea Limited
  • Thermo Fisher Scientific Inc.
  • Agilent Technologies, Inc.
  • Quest Diagnostics Incorporated
  • Illumina, Inc.
  • CooperSurgical, Inc.
  • Beijing Genomics Institute (BGI)
  • LabCorp of America Holdings (Laboratory Corporation of America)
  • Natera, Inc.
  • Oxford Gene Technology
  • California Pacific Medical Center
  • Good Start Genetics, Inc.
  • Invitae Corporation
  • F. Hoffmann-La Roche AG
  • Progenesis

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Snapshot, By Type
  • Market Snapshot, By End User
  • Market Snapshot, By Region
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Drivers
  • Restraints
  • Opportunities
• Impact Analysis
• Market Trends
• Key Developments
• Regulatory Scenario
• Acquisitions and Partnerships Scenario
• Funding and Investments
• PEST Analysis
• Porter's Analysis

4. Global Preimplantation Genetic Diagnosis Market - Impact of Coronavirus (COVID-19) Pandemic

• Overall Impact
• Government Initiatives
• COVID-19 Impact on the Market

5. Global Preimplantation Genetic Diagnosis Market, By Type, 2020 - 2032, (USD Mn)

• Overview
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Chromosomal Abnormalities
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
• Aneuploidy
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
• X-linked diseases
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
• Single gene disorders
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
• HLA Typing
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
• Gender Selection
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
• Others
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)

6. Global Preimplantation Genetic Diagnosis Market, By End User, 2020 - 2032, (USD Mn)

• Overview
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Diagnostic Laboratories
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
• Hospitals
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
• Clinics
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
• Others
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)

7. Global Preimplantation Genetic Diagnosis Market, By Region, 2020 - 2032, (USD Mn)

• Introduction
  • Market Share Analysis, By Region, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, For Region, 2021-2032
  • Regional Trends
• North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2020 - 2032, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Mn)
    • U.S.
    • Canada
• Latin America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2020 - 2032, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Mn)
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
• Europe
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2020 - 2032, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Mn)
    • U.K.
    • Germany
    • Italy
    • France
    • Spain
    • Russia
    • Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2020 - 2032, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Mn)
    • China
    • India
    • Japan
    • ASEAN
    • Australia
    • South Korea
    • Rest of Asia Pacific
• Middle East
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2020 - 2032, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Mn)
    • GCC Countries
    • Israel
    • Rest of Middle East
• Africa
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2020 - 2032, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Mn)
  • Forecast, and Y-o-Y Growth, By Country/Region, 2020 - 2032, (USD Mn)
    • North Africa
    • Central Africa
    • South Africa

8. Competitive Landscape

• Company Profiles
  • PerkinElmer, Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Genea Limited
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Thermo Fisher Scientific Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Agilent Technologies, Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Quest Diagnostics Incorporated
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Illumina, Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • CooperSurgical, Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Beijing Genomics Institute (BGI)
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • LabCorp of America Holdings (Laboratory Corporation of America)
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Natera, Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Oxford Gene Technology
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • California Pacific Medical Center
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Good Start Genetics, Inc.
  • Invitae Corporation
  • F. Hoffmann-La Roche AG
  • Progenesis

9. Analyst Recommendations

• Wheel of Fortune
• Analyst View
• Coherent Opportunity Map

10. References and Research Methodology

• References
• Research Methodology
• About Us and Sales Contact